| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.1M | -7.4% | -12.7% |
| Cost of Revenue | $3.2M | -8.1% | -0.1% |
| Gross Profit | $13.9M | -7.2% | -15.2% |
| R&D Expense | $3.7M | -26.8% | -31.0% |
| SG&A Expense | $7.2M | +8.4% | -24.6% |
| Operating Income | -$9.2M | +17.9% | +33.7% |
| Interest Expense | $1.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.4M | +26.2% | -17.3% |
| Short-term Investments | $7.9M | +127.1% | -69.4% |
| Accounts Receivable | $9.0M | -20.5% | -12.4% |
| Inventory | $7.2M | -3.9% | +16.2% |
| Current Assets | $41.4M | +14.1% | -35.3% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.8M | — | — |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | $12.4M | — | — |
| Financing Cash Flow | $14.7M | — | — |
| Free Cash Flow | -$27.4M | — | — |
| +1.3% |
| -6.7% |
| Pre-tax Income | -$13.2M | -32.8% | +18.9% |
| Income Tax | $15K | +275.0% | +153.6% |
| Net Income | -$13.2M | -32.9% | +18.6% |
| EPS (Basic) | -$0.46 | -21.1% | +25.8% |
| EPS (Diluted) | -$0.46 | -21.1% | +25.8% |
| $63.7M |
| +9.6% |
| -21.4% |
| Current Liabilities | $61.8M | -1.2% | +260.7% |
| Long-term Debt | $0 | -100.0% | -100.0% |
| Total Liabilities | $70.4M | -0.8% | +2.6% |
| Stockholders' Equity | -$6.7M | +48.3% | -154.5% |